# Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

> **NCT03372993** · — · COMPLETED · sponsor: **AryoGen Pharmed Co.** · enrollment: 200 (actual)

## Conditions studied

- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor
- Factor VII Deficiency
- Glanzmann's Thrombasthenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03372993
- **Lead sponsor:** AryoGen Pharmed Co.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-13
- **Primary completion:** 2021-03
- **Final completion:** 2021-04-15
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03372993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03372993, "Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03372993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*